Profile data is unavailable for this security.
About the company
Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
- Revenue in EUR (TTM)252.30m
- Net income in EUR12.15m
- Incorporated2018
- Employees1.47k
- LocationStratec SEGewerbestr. 37BIRKENFELD 75217GermanyDEU
- Phone+49 708279160
- Fax+49 70 827916999
- Websitehttps://www.stratec.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synektik SA | 138.39m | 17.69m | 282.23m | 164.00 | 15.95 | 7.88 | 14.25 | 2.04 | 8.94 | 8.94 | 69.92 | 18.10 | 2.12 | 14.61 | 9.11 | 3,897,992.00 | 27.09 | 10.24 | 44.28 | 15.79 | 26.38 | 22.86 | 12.78 | 8.85 | 1.17 | 13.77 | 0.1024 | 47.00 | 167.81 | -- | 409.18 | -- | -- | -- |
| COLTENE Holding AG | 249.90m | 12.30m | 286.08m | 1.20k | 23.23 | 2.87 | 14.78 | 1.14 | 2.00 | 2.00 | 40.62 | 16.21 | 1.33 | 1.40 | 6.58 | 201,937.60 | 6.53 | 10.48 | 10.90 | 18.74 | 64.24 | 62.68 | 4.92 | 7.47 | 0.8045 | 5.62 | 0.3172 | 79.94 | -9.13 | 3.54 | -54.05 | -6.81 | -7.72 | -7.79 |
| IVF Hartmann Holding AG | 152.33m | 15.60m | 311.34m | 304.00 | 19.97 | 2.00 | 14.63 | 2.04 | 6.31 | 6.31 | 61.63 | 63.07 | 0.8015 | 3.08 | 8.46 | 486,687.50 | 8.21 | 7.29 | 9.99 | 8.90 | 53.90 | 53.29 | 10.24 | 8.30 | 3.89 | -- | 0.0056 | 52.16 | -1.79 | 2.09 | 34.95 | 1.49 | -14.83 | 26.82 |
| RaySearch Laboratories AB (publ) | 92.29m | 8.86m | 335.88m | 398.00 | 48.80 | 6.33 | 9.76 | 3.64 | 2.94 | 2.94 | 30.64 | 22.65 | 0.5313 | 5.65 | 2.97 | 2,697,136.00 | 5.10 | 1.29 | 7.80 | 1.88 | 89.92 | 90.57 | 9.60 | 2.55 | 1.19 | 47.17 | 0.4036 | 69.00 | 21.16 | 10.26 | 243.06 | 0.7648 | -1.31 | -- |
| Ion Beam Applications SA | 428.72m | -9.11m | 369.44m | 1.99k | -- | 3.35 | 153.23 | 0.8617 | -0.3139 | -0.3139 | 14.72 | 3.64 | 0.702 | 2.54 | 2.65 | 215,869.60 | -1.49 | 1.55 | -5.92 | 4.32 | 31.36 | 35.23 | -2.12 | 2.38 | 0.7103 | 1.40 | 0.2814 | 64.83 | 18.67 | 10.74 | -250.40 | -- | -8.06 | -- |
| Guerbet SA | 785.69m | 23.87m | 455.08m | 2.92k | 20.01 | 1.20 | 5.46 | 0.5792 | 1.80 | 1.80 | 62.15 | 29.97 | 0.7997 | 0.5983 | 5.80 | 269,071.90 | 2.26 | 1.40 | 2.96 | 1.86 | 78.01 | 76.02 | 2.82 | 1.82 | 1.21 | 5.62 | 0.5035 | 57.82 | 4.30 | -0.0993 | 158.05 | -12.61 | 5.23 | -10.07 |
| CellaVision AB | 62.30m | 12.42m | 522.41m | 223.00 | 42.06 | 7.83 | 32.65 | 8.39 | 5.92 | 5.92 | 29.69 | 31.81 | 0.757 | 1.68 | 8.45 | 3,106,469.00 | 15.09 | 15.30 | 17.34 | 18.24 | 67.52 | 69.03 | 19.94 | 19.98 | 2.21 | 66.29 | 0.0688 | 110.18 | 5.94 | 13.17 | 10.12 | 8.00 | 30.45 | 8.45 |
| Surgical Science Sweden AB | 74.07m | 18.29m | 543.10m | 265.00 | 29.68 | 1.35 | 23.31 | 7.33 | 4.08 | 4.08 | 16.51 | 89.92 | 0.1749 | 1.68 | 6.12 | 3,238,531.00 | 4.32 | 4.49 | 4.59 | 4.78 | 68.59 | 70.06 | 24.70 | 23.75 | 3.53 | -- | 0.00 | 0.00 | 10.01 | 68.14 | 24.47 | -- | 38.57 | -- |
| Advanced Medical Solutions Group plc | 149.00m | 18.76m | 549.50m | 850.00 | 29.55 | 1.90 | 17.45 | 3.69 | 0.0724 | 0.0724 | 0.5755 | 1.12 | 0.4426 | 1.75 | 5.34 | 148,482.40 | 5.57 | 6.54 | 6.04 | 7.06 | 55.57 | 56.75 | 12.59 | 14.82 | 4.00 | -- | 0.0361 | 25.85 | 1.51 | 4.23 | -22.14 | -6.71 | 15.66 | 12.32 |
| Stratec SE | 252.30m | 12.15m | 554.40m | 1.47k | 45.64 | 2.42 | 18.34 | 2.20 | 0.9991 | 0.9991 | 20.75 | 18.86 | 0.5906 | 1.34 | 5.11 | 165,771.40 | 2.84 | 7.07 | 3.55 | 8.20 | 25.60 | 27.32 | 4.81 | 9.70 | 0.8029 | 4.41 | 0.3826 | 40.81 | -4.63 | 6.88 | -55.29 | 3.30 | -2.16 | -7.68 |
| medmix AG | 500.98m | 308.87k | 591.35m | 2.66k | 1,389.22 | 1.22 | 10.26 | 1.18 | 0.01 | 0.01 | 11.91 | 11.41 | 0.4606 | 3.65 | 6.05 | 183,070.00 | 0.0663 | 2.06 | 0.0846 | 2.49 | 32.41 | 36.38 | 0.1439 | 4.16 | 1.23 | 2.92 | 0.4244 | 67.70 | 1.99 | 1.40 | -97.41 | -64.36 | 12.01 | -- |
| Paul Hartmann AG | 2.35bn | 28.42m | 718.06m | 10.17k | 25.12 | 0.6713 | 5.29 | 0.3051 | 8.00 | 8.00 | 662.57 | 299.40 | 1.18 | 2.02 | 5.72 | 231,438.00 | 1.64 | 3.87 | 2.26 | 5.34 | 56.01 | 56.71 | 1.39 | 2.98 | 1.16 | 4.87 | 0.1865 | 42.75 | 1.80 | 2.12 | -21.37 | -18.49 | 5.95 | 2.71 |
| Revenio Group Oyj | 96.68m | 19.01m | 727.86m | 216.00 | 37.86 | 7.26 | 31.71 | 7.53 | 0.7205 | 0.7205 | 3.66 | 3.76 | 0.7069 | 5.50 | 7.60 | 447,574.10 | 13.90 | 14.33 | 16.77 | 17.90 | 51.01 | 50.73 | 19.66 | 21.13 | 1.79 | 28.49 | 0.1521 | 55.81 | -0.4125 | 25.80 | -12.15 | 18.72 | 17.67 | 6.30 |
| El En SpA | 692.29m | 48.24m | 752.69m | 2.11k | 15.57 | 2.17 | 12.16 | 1.09 | 0.6038 | 0.6038 | 8.67 | 4.33 | 0.9515 | 2.04 | 4.05 | 332,511.90 | 6.88 | 7.43 | 12.83 | 13.52 | 39.14 | 38.83 | 7.23 | 7.63 | 1.20 | 232.14 | 0.164 | -- | 2.78 | 14.88 | -12.47 | 23.49 | -13.40 | -- |
| ChemoMetec A/S | 53.83m | 19.28m | 809.11m | 171.00 | 41.98 | 12.10 | 37.21 | 15.03 | 8.26 | 8.26 | 23.07 | 28.66 | 0.6982 | 0.8064 | 6.01 | 2,448,421.00 | 25.00 | 30.43 | 29.69 | 38.99 | 78.85 | 79.44 | 35.81 | 34.17 | 3.37 | -- | 0.0118 | 46.90 | 3.74 | 31.58 | 12.04 | 57.88 | 19.91 | -- |
Data as of Jul 03 2024. Currency figures normalised to Stratec SE's reporting currency: Euro EUR
28.84%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brown Capital Management LLCas of 31 Mar 2024 | 980.57k | 8.07% |
| Invesco Advisers, Inc.as of 31 Dec 2023 | 609.88k | 5.02% |
| Juno Investment Partnersas of 31 Dec 2023 | 363.00k | 2.99% |
| Threadneedle Asset Management Ltd.as of 31 Dec 2023 | 346.29k | 2.85% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 253.29k | 2.08% |
| Candriam Belgium SAas of 30 Apr 2024 | 222.71k | 1.83% |
| Comgest SAas of 29 Feb 2024 | 213.64k | 1.76% |
| Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024 | 187.56k | 1.54% |
| Harding Loevner LPas of 30 Apr 2024 | 167.88k | 1.38% |
| Allianz Global Investors GmbHas of 30 Apr 2024 | 161.31k | 1.33% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
